Federal Circuit Upholds Rejection, Says Stent Patent Is Obvious
WASHINGTON, D.C. — Finding no error in a ruling by the Patent Trial and Appeal Board that invalidated, on obviousness grounds, 22 claims of a patented method of maintaining drugs delivered...To view the full article, register now.
Already a subscriber? Click here to view full article